Zentalis Pharmaceuticals Inc

NASDAQ:ZNTL   3:59:50 PM EDT
77.48
+1.68 (+2.22%)
Products

Zentalis Pharmaceuticals Announces U.S. FDA Fast Track Designation Uterine Serous Carcinoma Treatment

Published: 11/17/2021 12:25 GMT
Zentalis Pharmaceuticals Inc (ZNTL) - Zentalis Pharmaceuticals Announces Fast Track Designation Granted by the U.S. FDA to Zn-c3 for the Treatment of Uterine Serous Carcinoma.